{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:18:25Z","timestamp":1783099105562,"version":"3.54.6"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013365","name":"West China Hospital of Sichuan University","doi-asserted-by":"publisher","award":["2025HXBH008"],"award-info":[{"award-number":["2025HXBH008"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2025ZNSFSC1538"],"award-info":[{"award-number":["2025ZNSFSC1538"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370076"],"award-info":[{"award-number":["82370076"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bioorg.2026.109945","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T22:58:58Z","timestamp":1778108338000},"page":"109945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of ALK5 PROTAC degraders for pulmonary fibrosis"],"prefix":"10.1016","volume":"178","author":[{"given":"Lin","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailing","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conghui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taixiong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinghong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109945_bb0005","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1001\/jama.2024.3669","article-title":"Interstitial lung disease: a review","volume":"331","author":"Maher","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.bioorg.2026.109945_bb0010","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1164\/rccm.201806-1037ED","article-title":"Targeting the myofibroblast in pulmonary fibrosis","volume":"198","author":"Misharin","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bioorg.2026.109945_bb0015","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMra2005230","article-title":"Spectrum of fibrotic lung diseases","volume":"383","author":"Wijsenbeek","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.109945_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113714","article-title":"Matrix metalloproteinases inhibitors in idiopathic pulmonary fibrosis: medicinal chemistry perspectives","volume":"224","author":"Yue","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109945_bb0025","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41580-024-00716-0","article-title":"Fibroblast and myofibroblast activation in normal tissue repair and fibrosis","volume":"25","author":"Younesi","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.109945_bb0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00441-016-2464-0","article-title":"Epithelial-mesenchymal transition in tissue repair and fibrosis","volume":"365","author":"Stone","year":"2016","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bioorg.2026.109945_bb0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pccm.2024.02.001","article-title":"Dysregulated bidirectional epithelial-mesenchymal crosstalk: a core determinant of lung fibrosis progression","volume":"2","author":"Yao","year":"2024","journal-title":"Chin. Med. J. Pulm. Crit. Care Med."},{"key":"10.1016\/j.bioorg.2026.109945_bb0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pccm.2024.04.001","article-title":"Cell\u2013cell interactions and communication dynamics in lung fibrosis","volume":"2","author":"Xie","year":"2024","journal-title":"Chin. Med. J. Pulm. Crit. Care Med."},{"key":"10.1016\/j.bioorg.2026.109945_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117882","article-title":"Focal adhesion kinase inhibitors in fibrotic diseases therapy: development and therapeutic potential","volume":"296","author":"Gan","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109945_bb0050","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012131","article-title":"Inhibition of Aurora kinase B attenuates fibroblast activation and pulmonary fibrosis","volume":"12","author":"Kasam","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bioorg.2026.109945_bb0055","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1083\/jcb.200704042","article-title":"Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix","volume":"179","author":"Wipff","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.109945_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2023.104166","article-title":"Idiopathic pulmonary fibrosis","volume":"52","author":"Koudstaal","year":"2023","journal-title":"Presse Med."},{"key":"10.1016\/j.bioorg.2026.109945_bb0065","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","article-title":"The myofibroblast: one function, multiple origins","volume":"170","author":"Hinz","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bioorg.2026.109945_bb0070","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.109945_bb0075","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.109945_bb0080","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1056\/NEJMoa2414108","article-title":"Nerandomilast in patients with idiopathic pulmonary fibrosis","volume":"392","author":"Richeldi","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.109945_bb0085","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022053","article-title":"Signaling receptors for TGF-\u03b2 family members","volume":"8","author":"Heldin","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bioorg.2026.109945_bb0090","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.matbio.2018.03.021","article-title":"Idiopathic pulmonary fibrosis: epithelial-mesenchymal interactions and emerging therapeutic targets","volume":"71-72","author":"Hewlett","year":"2018","journal-title":"Matrix Biol. J. Int. Soc. Matrix Biol."},{"key":"10.1016\/j.bioorg.2026.109945_bb0095","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1183\/09031936.00073012","article-title":"The pathogenesis of pulmonary fibrosis: a moving target","volume":"41","author":"Wuyts","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bioorg.2026.109945_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030487","article-title":"TGF-\u03b2 Signaling","volume":"10","author":"Tzavlaki","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2026.109945_bb0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.molcel.2007.11.039","article-title":"Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding","volume":"29","author":"Groppe","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2026.109945_bb0110","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/370341a0","article-title":"Mechanism of activation of the TGF-beta receptor","volume":"370","author":"Wrana","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.109945_bb0115","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature10152","article-title":"Latent TGF-\u03b2 structure and activation","volume":"474","author":"Shi","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.109945_bb0120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.109945_bb0125","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/s41467-025-56796-9","article-title":"Structures of TGF-\u03b2 with betaglycan and signaling receptors reveal mechanisms of complex assembly and signaling","volume":"16","author":"Wieteska","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.109945_bb0130","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aav5183","article-title":"Specificity, versatility, and control of TGF-\u03b2 family signaling","volume":"12","author":"Derynck","year":"2019","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bioorg.2026.109945_bb0135","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S1357-2725(99)00093-X","article-title":"The Smads","volume":"31","author":"Hill","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.109945_bb0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pupt.2018.11.005","article-title":"Attenuation of pulmonary fibrosis in type I collagen-targeted reporter mice with ALK-5 inhibitors","volume":"54","author":"Terashima","year":"2019","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2026.109945_bb0145","first-page":"1129","article-title":"The anti-fibrotic effect of inhibition of TGF\u03b2-ALK5 signalling in experimental pulmonary fibrosis in mice is attenuated in the presence of concurrent \u03b3-herpesvirus infection","volume":"8","author":"Smoktunowicz","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bioorg.2026.109945_bb0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.yexmp.2006.12.003","article-title":"Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis","volume":"83","author":"Higashiyama","year":"2007","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bioorg.2026.109945_bb0155","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1021\/jm500115w","volume":"57","author":"Jin","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109945_bb0160","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s10637-019-00835-y","article-title":"Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study","volume":"38","author":"Jung","year":"2020","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.bioorg.2026.109945_bb0165","series-title":"Preparation of Aminopyridyloxypyrazole Compounds as TGF\u03b2R1 Inhibitors","author":"McMillen","year":"2016"},{"key":"10.1016\/j.bioorg.2026.109945_bb0170","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1158\/1078-0432.CCR-21-1504","article-title":"First-in-human phase I study of a next-generation, Oral, TGF\u03b2 receptor 1 inhibitor, LY3200882, in patients with advanced Cancer","volume":"27","author":"Yap","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.109945_bb0175","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1186\/s12885-023-11153-1","article-title":"A phase Ib\/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer","volume":"23","author":"Nadal","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bioorg.2026.109945_bb0180","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s12885-024-12216-7","article-title":"First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-\u03b2 receptor I inhibitor, in patients with advanced solid tumors","volume":"24","author":"Guo","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bioorg.2026.109945_bb0185","doi-asserted-by":"crossref","first-page":"ra2","DOI":"10.1126\/scisignal.2004207","article-title":"TRAF6 stimulates the tumor-promoting effects of TGF\u03b2 type I receptor through polyubiquitination and activation of presenilin 1","volume":"7","author":"Gudey","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bioorg.2026.109945_bb0190","doi-asserted-by":"crossref","first-page":"279","DOI":"10.18632\/oncotarget.6346","article-title":"APPL proteins promote TGF\u03b2-induced nuclear transport of the TGF\u03b2 type I receptor intracellular domain","volume":"7","author":"Song","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2026.109945_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103395","article-title":"PROTAC technology: a new drug design for chemical biology with many challenges in drug discovery","volume":"28","author":"Guedeney","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2026.109945_bb0200","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1039\/D2CS00200K","article-title":"Target and tissue selectivity of PROTAC degraders","volume":"51","author":"Guenette","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2026.109945_bb0205","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1016\/j.bmcl.2016.07.030","article-title":"Design, synthesis and optimization of novel Alk5 (activin-like kinase 5) inhibitors","volume":"26","author":"Wang","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109945_bb0210","doi-asserted-by":"crossref","first-page":"26704","DOI":"10.1021\/acsnano.4c06598","article-title":"Tetrahedral framework nucleic acids delivery of pirfenidone for anti-inflammatory and antioxidative effects to treat idiopathic pulmonary fibrosis","volume":"18","author":"Xie","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioorg.2026.109945_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117232","article-title":"Design, synthesis, and biological evaluation of a potent and orally bioavailable FGFRs inhibitor for fibrotic treatment","volume":"285","author":"Yue","year":"2025","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:30:19Z","timestamp":1783096219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826004815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":43,"alternative-id":["S0045206826004815"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109945","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of ALK5 PROTAC degraders for pulmonary fibrosis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109945","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109945"}}